Glenmark the first company to launch Favipiravir in India now launches 400 mg tablets... Aug 06
Phase 3 Trial demonstrates statistically significant faster time to clinical improvement with Favipiravir treatment in mild to moderate COVID 19 patients... Jul 23
-Advertisements-